Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
JAAD Case Reports
|
April 14, 2025
An eczematous eruption with features of prurigo nodularis: An unexpected presentation of alpha-gal syndrome
Shaun Wu, Emily R Nadelmann, Merav Koschitzky, et al.
Archives of Dermatology
|
October 19, 2011
Erythematous patches and plaques on the chest with induration of the breasts. Metastatic papillary RCC in dermal lymphatics
Yevgeniy Balagula, Natalia Jaimes-Lopez, Natalia Jaimes Lopez, et al.
JAAD Case Reports
|
March 12, 2019
A unique clinical and histologic presentation of catastrophic systemic calciphylaxis in a nonuremic patient with systemic lupus erythematosus
Alexandra K Rzepecki, Michelle Park, Bijal Amin, et al.
Archives of Dermatology
|
January 18, 2012
White shiny structures in melanoma and BCC
Tracey N Liebman, Harold S Rabinovitz, Yevgeniy Balagula, et al.
Journal of Graduate Medical Education
|
September 4, 2020
Relationship Between Scholarly Activity and Postgraduate Career Choice: A Bibliometric Analysis of the 2017 Diplomates of the American Board of Dermatology
Anthony K Guzman, Alexandra K Rzepecki, Gary D Lewis, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 27, 2010
Keratoacanthomas associated with imatinib mesylate
Yevgeniy Balagula, Klaus J Busam, Richard D Carvajal, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 15, 2021
The Role of Early Subspeciality Consultation in the Timing of Hemophagocytic Lymphohistiocytosis Diagnosis and Management
Sneha Patel, Ayesha Bibi, Ruth Eisenberg, et al.
Investigational New Drugs
|
October 28, 2010
Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)
Yevgeniy Balagula, Katherine Barth Huston, Klaus J Busam, et al.
The Oncologist
|
April 12, 2013
In reply
Alyx C Rosen, Igor T Gavrilovic, Yevgeniy Balagula, et al.
The Oncologist
|
January 28, 2012
Characteristics of oral mucosal events related to bevacizumab treatment
Igor T Gavrilovic, Yevgeniy Balagula, Alyx C Rosen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
JAAD Case Reports
|
April 14, 2025
An eczematous eruption with features of prurigo nodularis: An unexpected presentation of alpha-gal syndrome
Shaun Wu, Emily R Nadelmann, Merav Koschitzky, et al.
Archives of Dermatology
|
October 19, 2011
Erythematous patches and plaques on the chest with induration of the breasts. Metastatic papillary RCC in dermal lymphatics
Yevgeniy Balagula, Natalia Jaimes-Lopez, Natalia Jaimes Lopez, et al.
JAAD Case Reports
|
March 12, 2019
A unique clinical and histologic presentation of catastrophic systemic calciphylaxis in a nonuremic patient with systemic lupus erythematosus
Alexandra K Rzepecki, Michelle Park, Bijal Amin, et al.
Archives of Dermatology
|
January 18, 2012
White shiny structures in melanoma and BCC
Tracey N Liebman, Harold S Rabinovitz, Yevgeniy Balagula, et al.
Journal of Graduate Medical Education
|
September 4, 2020
Relationship Between Scholarly Activity and Postgraduate Career Choice: A Bibliometric Analysis of the 2017 Diplomates of the American Board of Dermatology
Anthony K Guzman, Alexandra K Rzepecki, Gary D Lewis, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 27, 2010
Keratoacanthomas associated with imatinib mesylate
Yevgeniy Balagula, Klaus J Busam, Richard D Carvajal, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
July 15, 2021
The Role of Early Subspeciality Consultation in the Timing of Hemophagocytic Lymphohistiocytosis Diagnosis and Management
Sneha Patel, Ayesha Bibi, Ruth Eisenberg, et al.
Investigational New Drugs
|
October 28, 2010
Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)
Yevgeniy Balagula, Katherine Barth Huston, Klaus J Busam, et al.
The Oncologist
|
April 12, 2013
In reply
Alyx C Rosen, Igor T Gavrilovic, Yevgeniy Balagula, et al.
The Oncologist
|
January 28, 2012
Characteristics of oral mucosal events related to bevacizumab treatment
Igor T Gavrilovic, Yevgeniy Balagula, Alyx C Rosen, et al.
Page
of 6